Home / Author Archives: Nasdaq NewsFeed (page 4)

Author Archives: Nasdaq NewsFeed

Elite Pharmaceuticals Acquires Trimipramine ANDA

NORTHVALE, N.J., May 22, 2017 (GLOBE NEWSWIRE) — Elite Pharmaceuticals, Inc. (“Elite” or the “Company”) (OTCBB:ELTP), today announced the acquisition of an approved and currently marketed Abbreviated New Drug Application (“ANDA”) for Trimipramine Maleate Capsules (“Trimipramine”) 25, 50 and 100 ...

Read More »

CareDx Reports Preliminary First Quarter 2017 Financial Results

BRISBANE, Calif., May 22, 2017 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients, today reported preliminary financial results for the first quarter ended March ...

Read More »

Tonix Pharmaceuticals Presented Analyses of Potential Moderators of Treatment Response to U.S. FDA-Designated Breakthrough Therapy for PTSD, TNX-102 SL, in Phase 2 AtEase Study in Military-Related PTSD

NEW YORK, May 22, 2017 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq:TNXP) (Tonix), a company that is developing innovative pharmaceutical products to address public health challenges, presented a poster on May 20, 2017, entitled “Phase 2 Multisite Double-Blind Placebo-Controlled ...

Read More »